Gene expression profiling in pachyonychia congenita skin

被引:29
|
作者
Cao, Yu-An [1 ]
Hickerson, Robyn P. [1 ]
Seegmiller, Brandon L. [1 ]
Grapov, Dmitry [2 ]
Gross, Maren M. [3 ]
Bessette, Marc R. [3 ]
Phinney, Brett S. [2 ]
Flores, Manuel A. [1 ]
Speaker, Tycho J. [1 ]
Vermeulen, Annaleen [3 ]
Bravo, Albert A. [4 ]
Bruckner, Anna L. [5 ]
Milstone, Leonard M. [6 ]
Schwartz, Mary E. [7 ]
Rice, Robert H. [2 ]
Kaspar, Roger L. [1 ]
机构
[1] TransDerrn Inc, Santa Cruz, CA 95060 USA
[2] Univ Calif Davis, Davis, CA 95616 USA
[3] Dharmacon Part GE Healthcare, Lafayette, CO 80026 USA
[4] Podiatr Med & Surg, Pittsfield, MA 01201 USA
[5] Univ Colorado, Sch Med, Aurora, CO 80045 USA
[6] Yale Univ, New Haven, CT 06520 USA
[7] Pachyonychia Congenita Project, Salt Lake City, UT 84109 USA
关键词
Painful palmoplantar keratoderma; Genodermatosis; Monogenic skin disorder; mTOR signaling pathway; Keratinocyte; Desquamation; EPIDERMOLYTIC PALMOPLANTAR KERATODERMA; KERATIN; 9; ECTODERMAL DYSPLASIA; LAMELLAR GRANULES; MOLECULAR-CLONING; PROTEIN-SYNTHESIS; NAIL DEFECTS; MUTATION; DISEASE; PSORIASIS;
D O I
10.1016/j.jdermsci.2015.01.001
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Pachyonychia congenita (PC) is a skin disorder resulting from mutations in keratin (K) proteins including K6a, K6b, K16, and K17. One of the major symptoms is painful plantar keratoderma. The pathogenic sequelae resulting from the keratin mutations remain unclear. Objective: To better understand PC pathogenesis. Methods: RNA profiling was performed on biopsies taken from PC-involved and uninvolved plantar skin of seven genotyped PC patients (two K6a, one K6b, three K16, and one K17) as well as from control volunteers. Protein profiling was generated from tape-stripping samples. Results: A comparison of PC-involved skin biopsies to adjacent uninvolved plantar skin identified 112 differentially-expressed mRNAs common to patient groups harboring K6 (i.e., both K6a and K6b) and K16 mutations. Among these mRNAs, 25 encode structural proteins including keratins, small proline-rich and late cornified envelope proteins, 20 are related to metabolism and 16 encode proteases, peptidases, and their inhibitors including kallikrein-related peptidases (KLKs), and serine protease inhibitors (SERPINs). mRNAs were also identified to be differentially expressed only in K6 (81) or K16 (141) patient samples. Furthermore, 13 mRNAs were identified that may be involved in pain including nociception and neuropathy. Protein profiling, comparing three K6a plantar tape-stripping samples to non-PC controls, showed changes in the PC corneocytes similar, but not identical, to the mRNA analysis. Conclusion: Many differentially-expressed genes identified in PC-involved skin encode components critical for skin barrier homeostasis including keratinocyte proliferation, differentiation, cornification, and desquamation. The profiling data provide a foundation for unraveling the pathogenesis of PC and identifying targets for developing effective PC therapeutics. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:156 / 165
页数:10
相关论文
共 50 条
  • [21] PACHYONYCHIA CONGENITA
    JENSEN, AK
    ARCHIVES OF DERMATOLOGY, 1960, 81 (06) : 1019 - 1021
  • [22] Pachyonychia Congenita
    Yan Tan
    Dong-Lai Ma
    Indian Journal of Pediatrics, 2024, 91 : 300 - 301
  • [23] PACHYONYCHIA CONGENITA
    SIVASUNDRAM, A
    RAJAGOPALAN, K
    SAROJINI, T
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1985, 24 (03) : 179 - 180
  • [24] PACHYONYCHIA CONGENITA
    LAING, CR
    HAYES, JR
    SCHARF, G
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1966, 111 (06): : 649 - &
  • [25] Development of Skin-Humanized Mouse Models of Pachyonychia Congenita
    Garcia, Marta
    Larcher, Fernando
    Hickerson, Robyn P.
    Baselga, Eulalia
    Leachman, Sancy A.
    Kaspar, Roger L.
    Del Rio, Marcela
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (05) : 1053 - 1060
  • [26] Gene editing for ex vivo pachyonychia congenita correction
    Diez, M. Garcia
    Sot, B.
    Moreno, M.
    Morin, M.
    Soletto, L.
    Fernandez, S.
    Prado, D.
    Murillas, R.
    Mencia, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S149 - S149
  • [27] First-in-skin siRNA clinical trial for pachyonychia congenita
    Leachnnan, S. A.
    Hickerson, R. P.
    Schwartz, M. E.
    Smith, F. I.
    Mclean, W.
    Milstone, L. M.
    Kispar, R. L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S79 - S79
  • [28] Treatment of pachyonychia congenita
    Milstone, LM
    Fleckman, P
    Leachman, SA
    Leigh, IM
    Paller, AS
    van Steensel, MAM
    Swartling, C
    JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2005, 10 (01) : 18 - 20
  • [29] Pachyonychia congenita tarda
    MouaciMidoun, N
    Cambiaghi, S
    Abimelec, P
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 35 (02) : 334 - 335
  • [30] Pachyonychia congenita (PC)
    Bassioukas, K
    Nakuci, MM
    Christophorou, N
    Ioannou, M
    Andreou, E
    Hatzis, J
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 1997, 9 (02) : 188 - 190